The rapid growth of the specialty pharmacy market (projected to grow to $500 billion by 2020) has resulted in a large volume of complex data that can be overwhelming for pharmaceutical manufacturers (pharmas) seeking to obtain (and understand) Specialty Drug Data. They face the challenges of identifying data for analytics based on availability and then, once selected, pulling it all together.